A rapid review of the prevalence and onset of urticaria triggered by COVID-19 vaccine [version 2; peer review: awaiting peer review]
Background: The Coronavirus Disease 2019 (COVID-19) vaccine is essential to reduce the spread of this disease virus and is very effective at preventing patients with severe symptoms of the disease from dying. As of February 2022, more than 10 billion doses of the COVID-19 vaccine have been administe...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis
2022
|
| Subjects: | |
| Online Access: | https://repository.ugm.ac.id/279012/1/Fadhal_KKMK.pdf |